NeuroFrontiers

Understanding Variability in Myasthenia Gravis

May 1, 2026 • 0 secs

Examining the Global Genetic Prevalence of TK2d

Apr 30, 2026 • 0 secs

Advances in Cell-Based Therapy for MS

Apr 20, 2026 • 0 secs

Next-Generation MS Care: The Promise of Cell-Based Therapeutics

Apr 20, 2026 • 0 secs

Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis

Mar 30, 2026 • 0 secs